President Trump announced a deal with UK drug manufacturer AstraZeneca on Oct. 10. The pharmaceutical company will have a new drug pricing model on the government’s platform dubbed "TrumpRx," which will include more affordable prices. Trump also said the company will also invest $50 billion in US research, development, and drug manufacturing.
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Check out our two new podcasts:
Pod Force One with Miranda Devine (weekly): https://www.youtube.com/@PodForce1
NY POSTcast (daily): https://www.youtube.com/@NYPOSTcast
Get The Post’s latest headlines everyday with our Morning Report newsletter:
https://tinyurl.com/NYPOSTSIGNUP
Catch the latest news at http://www.nypost.com.
Follow The New York Post on:
Twitter – https://twitter.com/nypost
Facebook – https://www.facebook.com/NYPost
